Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$345,000
$69.52 P/Share
|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-90.0%
|
$268,000
$67.67 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-97.7%
|
$134,000
$67.84 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-87.39%
|
$272,000
$68.34 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$48,000
$12.15 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$340,000
$68.34 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
5,000
-63.73%
|
$335,000
$67.43 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+38.93%
|
$55,000
$11.33 P/Share
|
|
Jun 28
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-68.64%
|
$345,000
$69.93 P/Share
|
|
Jun 28
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Jun 20
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-74.12%
|
$345,000
$69.12 P/Share
|
|
Jun 20
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Jun 16
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,331
-100.0%
|
$542,494
$74.0 P/Share
|
|
Jun 16
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,331
+50.0%
|
$175,944
$24.9 P/Share
|
|
Jun 14
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,669
-53.43%
|
$340,837
$73.96 P/Share
|
|
Jun 14
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,669
+50.0%
|
$112,056
$24.9 P/Share
|
|
Jun 14
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,333
-51.78%
|
$394,642
$74.03 P/Share
|
|
Jun 14
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+50.0%
|
$58,663
$11.12 P/Share
|
|
Jun 07
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,000
-70.75%
|
$1,349,000
$71.53 P/Share
|
|
Jun 07
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+33.7%
|
$380,000
$20.98 P/Share
|
|
Jun 07
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
20,000
-70.49%
|
$1,420,000
$71.45 P/Share
|
|
Jun 07
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.43%
|
$240,000
$12.84 P/Share
|
|
May 31
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-74.83%
|
$325,000
$65.11 P/Share
|
|
May 31
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
May 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-78.23%
|
$370,000
$74.05 P/Share
|
|
May 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
May 17
2023
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
45,000
-37.75%
|
$3,285,000
$73.6 P/Share
|
|
May 17
2023
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+43.78%
|
$1,305,000
$29.81 P/Share
|
|
May 17
2023
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
95,000
-41.36%
|
$7,030,000
$74.45 P/Share
|
|
May 17
2023
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+41.01%
|
$2,470,000
$26.33 P/Share
|
|
May 03
2023
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
15,000
-84.06%
|
$855,000
$57.0 P/Share
|
|
May 03
2023
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+36.97%
|
$240,000
$16.6 P/Share
|
|
Apr 26
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-96.8%
|
$265,000
$53.83 P/Share
|
|
Apr 26
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Apr 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-79.17%
|
$260,000
$52.95 P/Share
|
|
Apr 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Mar 29
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-77.34%
|
$245,000
$49.05 P/Share
|
|
Mar 29
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Mar 20
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.03%
|
$235,000
$47.99 P/Share
|
|
Mar 20
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Mar 15
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,000
-75.0%
|
$576,000
$48.41 P/Share
|
|
Mar 15
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$288,000
$24.9 P/Share
|
|
Mar 15
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-71.45%
|
$720,000
$48.4 P/Share
|
|
Mar 15
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$150,000
$10.27 P/Share
|
|
Mar 15
2023
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-49.14%
|
$480,000
$48.42 P/Share
|
|
Mar 15
2023
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|